The Cigna Group (CI) Financial Statements
Historical financial data — 30 statements covering FY2018–FY2025
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are...
The Cigna Group's revenue increased 11.2% year over year, from $247.12B to $274.90B.
Net income increased 73.5% over the same period, from $3.43B to $5.96B.
Over the 7-year period from FY2018 to FY2025, revenue grew by 465% in total.
Total debt remained relatively stable at $31.46B.
The debt-to-equity ratio stands at 0.75, indicating a moderate leverage profile.
Operating cash flow declined 7.4% to $9.60B.
The Cigna Group maintains a moderate net profit margin of 2.2%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $144.15B+51.6% | $4.13B | $45.61B | $6.48B | $10.35B | $149.65B | $31.14B | $45.69B |
| Q1 FY2024 | $57.26B-60.3% | $-277.0M | $15.82B | $2.26B | $4.84B | $153.12B | $32.77B | $41.18B |
| Q2 FY2024 | $117.78B+105.7% | $1.27B | $31.86B | $4.67B | $5.11B | $155.45B | $31.89B | $41.33B |
| Q3 FY2024 | $181.47B+54.1% | $2.01B | $47.98B | $7.24B | $5.15B | $157.64B | $32.80B | $42.09B |
| Q1 FY2025 | $65.50B-63.9% | $1.32B | $17.10B | $1.97B | $1.92B | $150.66B | $30.45B | $40.23B |
| Q2 FY2025 | $132.68B+102.6% | $2.85B | $31.01B | $4.28B | $34.0M | $151.65B | $30.77B | $40.21B |
| Q3 FY2025 | $202.43B+52.6% | $4.72B | $45.23B | $6.86B | $3.45B | $157.92B | $34.04B | $41.80B |
| Q1 FY2026 | $68.49B-66.2% | $1.65B | $14.39B | $2.36B | $1.13B | $153.27B | $30.90B | $42.21B |
Balance Sheet Summary (Latest Period)
Total Assets
$157.92B
Total Liabilities
$116.05B
Total Equity
$41.71B
Cash & Equivalents
$8.73B
Total Debt
$31.46B
Current Assets
$47.81B
Current Liabilities
$56.34B
Retained Earnings
$47.87B